Results 111 to 120 of about 1,428 (167)

Effects of Progranulin Deficiency on Inflammation and Fibrosis in the Kidneys and Liver of Diabetic Mice Fed a High-Fat Diet. [PDF]

Endocrinol Metab (Seoul)
Sakuma H, Murakoshi M, Hagiwara S, Shibata T, Suzuki Y, Gohda T.   +5 more
europepmc   +1 more source

Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima-Media Thickness in Patients With Cardiovascular Disease and/or Diabetes-A Systematic Review. [PDF]

Endocrinol Diabetes Metab
Shabu A, Naqvi SM, Hesari F, Naqvi SY, Tawfick W.   +4 more
europepmc   +1 more source

Pharmacokinetic Landscape and Interaction Potential of SGLT2 Inhibitors: Bridging In Vitro Findings and Clinical Implications. [PDF]

Pharmaceutics
Koo N, Lee EJ, Chang JE, Lee KR, Chae YJ.   +4 more
europepmc   +1 more source

A decade of SGLT2 inhibitors: Lessons learned and the road ahead in type 2 diabetes. [PDF]

J Diabetes Investig
Kimura T, Kaku K.
europepmc   +1 more source

Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients.

Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients.
令和3年度 Recent studies have shown that sodium glucose cotransporter 2 (SGLT2) inhibitors have a favorable effect on cardiovascular events in diabetic patients. However, the underlying mechanism associated with a favorable outcome has not been clearly identified. The purpose of this study was to investigate the effect of tofogliflozin, SGLT2 inhibitor, on
openaire   +1 more source

Comparison of the efficacy of antidiabetic agents in type 2 diabetes with MASLD: a network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Shao X, You J, Zhang H, Jiang X.
europepmc   +1 more source

Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. [PDF]

Hepatology
Qi X, Li J, Caussy C, Teng GJ, Loomba R.
europepmc   +1 more source

Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Clin Exp Med
Zhang YF, Xie JJ, Wu Q, Zhou XY, Zeng C, Zeng Y, He YM, Guo M, Teng FY, Xu Y.   +9 more
europepmc   +1 more source

Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin?

Archives of Medical Science – Atherosclerotic Diseases, 2018
openaire   +2 more sources

From molecules to the clinic-pathophysiology of sodium-glucose cotransporter 2 inhibitors and their emerging role in urology: A comprehensive review from the European Association of Urology Section of Endourology. [PDF]

Asian J Urol
Talyshinskii A, Gauhar V, Kar Kei Yuen S, Güven S, Tokas T, Tsaturyan A, Enikeev D, Somani B.   +7 more
europepmc   +1 more source